speakers
speaker list | presenting companies
The BioBay Investor Forum - presented by ChinaBio® features speakers from the US and China that are renowned experts in their fields, including:
- The State of the China Biotech Industry - China's biotech and life science industry is rapidly becoming a global force. And Suzhou is playing an important part in its growth.
- Attacting Early Stage Capital - Learn what US and China investors are looking for in early and mid-stage biotechnology, diagnostics and services companies, and hear entrepreneurs tell their success stories.
- Structuring a Global Biotech - How to set up a global biotech in China using US, BVI, Cayman, WFOE, holding companies, subsidiaries, etc.
- Building an IP Portfolio - How to create a patent portfolio that will protect your intellectual property globally.
- Reducing Costs and Risks through Outsourcing - How to reduce your costs and improve the return on investment by using CROs and CMOs to perform much of the work in drug development.
Speaker List
The following industry experts will be providing insights into China's emerging biotechnology industry and how to launch and build a successful life science companies at the BioBay Investor Forum. (Click here for Speaker Bios.)
ChinaBio® Executive Workshop Speakers:
Kewen Jin, PhD – CEO, Charles River Laboratories (China)
Greg B. Scott – President and Founder, ChinaBio®
Zoe Wang, PhD, JD – Partner, Perkins Coie LLP
Wei Zhou, PhD, JD – Partner, Wilson Sonsini Goodrich & Rosati (WSGR)
BioBay Investor Forum Speakers and Panelists:
Amir Gal-Or, MBA – Managing Partner, Infinity Equity
William Hu, MBA – Principal, Qiming Venture Partners
Karen Liu, PhD, VP - China Renaissance Capital Investment
Yuwen Liu – General Manager, BioBay
Don Qiu, PhD, MBA – General Manager, China, ChinaBio® LLC
Yi Shi, PhD – Managing Director, Lilly Asian Ventures
David Xu, PhD - Managing Partner, Mingly China Growth Fund
Michael Xu, MD, PhD – CEO, PegBio Co., Ltd
Robert Li, PhD –Partner, BioVeda China
Qimin Zhan, MD – Chief Scientist, State 863 Program
Dongchi Zhang - Director, Science & Technology Bureau, Suzhou Industrial Park
Peter Zhang, PhD - Chairman & CEO, Suzhou GenePharma Co., Ltd.
Presenting Companies
The following companies will be presenting at the BioBay Investor Forum. (Final List)
|
Company / Speaker
|
Description
|
4D Pharmaceuticals Inc. (USA/China)
Yongliang Zhu, PhD, Founder & President |
Novel drugs for the treatment of inflammation, cancer and CNS diseases |
Ascepion Pharmaceuticals, Inc.
Shan Jiang, PhD, CEO |
Novel small molecule kinase inhibitor drugs |
Botanovation (Suzhou) Bioscience
Kevin Xu, MD, PhD, MBA CEO & Founder |
Botanical technologies and products |
CareRay Digital Medical System
Jianqiang Liu, PhD, Founder, CTO & CEO |
X-ray flat-panel detector in medical Industry |
GeneDiag Biotech (Suzhou)
Jingde Zhu, PhD, CSO & President |
DNA methylation diagnotic products for cancer |
Suzhou GenePharma Co., Ltd.
Peter Zhang, PhD, Chairman & CEO |
RNAi based services, products, diagnostic kits and therapeutics |
Suzhou Goodee Pharmaceutical
Guoxia Han, PhD, Co-founder & CEO |
Novel anti-tumor drug discovery |
Suzhou Harmony Biotechnology
Janckie Zhu, VP |
Novel drugs and synthesis contract research services |
Innogene Biotech Ltd. (Canada/China)
Qinghua Wang, MD, PhD, CEO & Founder |
Novel drugs for the treatment of type 1 and type 2 diabetes |
Kintor Pharmaceuticals, Inc. (USA/China)
Youzhi Tong, PhD, President |
Signal transduction drugs for targeted cancer therapy |
NuHigh Biotechnologies Co., Ltd. (USA/China)
Wanli Bi, PhD, CTO |
Nucleic acid testing of blood supply |
Suzhou Scientific Solution Co., Ltd.
Yongtai Hou, PhD, Chairman & CEO |
Nanotechnology platform to improve drug solubility |
SinoVitae Pharmaceuticals, Inc. (USA/China)
Augustine Lin, PhD, CEO & President |
Point-of-care therapeutic diagnostic products |
Suzhou Sirnaomics Biopharmaceuticals Co., Ltd.
Patrick Lu, PhD, CEO |
Drug development based on siRNA technologies |
Stainwei Biotech, Inc. (Suzhou)
Qunmin (Jim) Zhou, MD, PhD, Founder & President |
Novel antibody based anti-tumor angiogenesis drugs |
Viagene Biotech, Inc. (USA/China)
Richard Y Liu, MD, CEO & Founder |
Novel technologies & products for research and diagnosis |
>> Click here to register
|
|
